FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is used for the long-term treatment of chronic obstructive pulmonary disease (COPD) and asthma. COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing.
FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is a combination of three drugs: Fluticasone furoate (corticosteroid), Umeclidinium (anticholinergic) and Vilanterol (long-acting beta-agonist). Together, they work by relaxing and opening air passages in the lungs. Thus, it makes breathing easier.
FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is for inhalation only. Use FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL as advised by your doctor. You are advised to use FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL for as long as your doctor has advised it based on your medical condition. FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL may cause common side effects such as common cold, sore, raised patches in the throat or mouth caused by a fungal infection (thrush), hoarseness, cough, headache, back pain, painful and frequent urination, and itchy, runny or blocked nose. Most of these side effects of FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Vilanterol, Fluticasone furoate, Umeclidinium or any other ingredients in FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL, tell your doctor. If you have severe milk protein or a lactose allergy, inform your doctor. FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL may cause blurred vision and headaches. Therefore, use caution when driving or operating heavy machinery until you know how FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL affects you. Avoid coming into contact with people who have chicken pox or measles while taking FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL. If you are exposed, tell your doctor immediately.
FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL belongs to the class of respiratory stimulants. FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL contains Fluticasone furoate, Umeclidinium and Vilanterol. Fluticasone furoate reduces inflammation in the airways of the lungs. Thus, it helps to ease breathing problems in COPD and asthma patients. Umeclidinium and Vilanterol work together to help open and relax the muscles in the airways and make it easier for air to get in and out of the lungs. FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is used to control symptoms such as shortness of breath, wheezing (whistling sound while breathing), chest tightness and coughing caused by COPD and asthma.
If you are allergic to Umeclidinium, Fluticasone furoate, Vilanterol or any other ingredients in FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL, tell your doctor. If you have severe milk protein or a lactose allergy, inform your doctor. When FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is used for long-term treatment, you may be at risk of weak bones (osteoporosis; increased risk of broken bones) and breaking a bone (bone fractures). Therefore, take extra care to avoid any injury, especially falls. Avoid coming into contact with people who have chicken pox or measles while taking FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL. If you are exposed, tell your doctor immediately. FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL may cause eye problems. If you experience any eye problems while using FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL, contact your doctor right away. Also, you should have regular eye check-ups. Do not take more than the recommended dose as it may cause an overdose, resulting in symptoms such as dry mouth, feeling shaky, blurred vision, headache or feeling that your heart is beating faster than usual.
Drug-Drug Interaction: FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL may interact with bronchodilators (formoterol fumarate, indacaterol, salmeterol, olodaterol, tiotropium, aclidinium, glycopyrronium, umeclidinium), antifungals (voriconazole, ketoconazole, itraconazole), medicines used to treat HIV/AIDS (lopinavir, nelfinavir, ritonavir, indinavir, saquinavir, atazanavir, cobicistat-containing products), antibiotic (clarithromycin), diuretics (water pills), antidepressants, medicines used to lower blood pressure (propranolol), medicine used to treat glaucoma (timolol).
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have high blood pressure, diabetes, thyroid gland problems, low potassium levels in the blood, glaucoma, cataracts, changes in the vision, prostate or bladder problems, immune system/heart/liver problems, or ever had seizures (fits), thrush or yeast infection in the mouth, herpes simplex of the eye, tuberculosis, or any type of viral, bacterial, fungal (yeast), or parasitic infection, inform your doctor.
The interaction of FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL with alcohol is unknown. If you have any concerns, please discuss them with your doctor.
FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is given to pregnant women only if the doctor thinks the benefits outweigh the risks. Therefore, inform your doctor if you are pregnant before using FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL.
It is unknown whether FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is excreted in human milk. Therefore, if you are a nursing mother, please discuss with your doctor before using FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL.
FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL may cause blurred vision and headaches. Therefore, use caution when driving or operating heavy machinery until you know how FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL affects you.
If you have liver disease, inform your doctor before using FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL. The dose may be adjusted by your doctor as required.
If you have any concerns regarding the use of FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL in patients with kidney disease, discuss them with your doctor.
FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL is not recommended for children and adolescents below 18 years of age.
Your doctor may test your bone mineral density (BMD) before you start taking FLUTICASONE FUROATE+UMECLIDINIUM+VILANTEROL and periodically during treatment.
Chronic obstructive pulmonary disease (COPD): It is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes). The primary cause of COPD is smoking tobacco. Also, long-term exposure to fumes and chemicals may lead to COPD. The symptoms include chronic cough, shortness of breath, or wheezing (whistle sound while breathing).
Asthma: It is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. The symptoms of asthma include wheezing (whistling sound while breathing), shortness of breath, chest tightness, and cough, especially at night. The symptoms of mild persistent asthma may occur more than 2 times a week and up to 4 nights in a month, whereas, in the case of severe persistent asthma, the symptoms occur several times every day and most nights. The asthma treatment includes medication, breathing exercises, and self-care.